Seminar Title: “The roles of lncRNAs in drug metabolism and drug-induced toxicity”
Wednesday, October 5, from 3:30 – 4:30 PBB 131 & WebEX
https://uconn-cmr.webex.com/uconn-cmr/j.php?MTID=mde28f86b1b884e4ee3d89ff48b504f94
Dr. Zhong is a professor and coordinator of Pharmacology and Toxicology graduate program in the Department of Pharmaceutical Sciences of School of Pharmacy at the University of Connecticut (UConn). He received a B.Sc. degree in Biology from Peking University, Beijing, China and a Ph.D. degree in Molecular Biology from Wageningen University, The Netherlands. He was trained as a postdoctoral fellow in Human Genetics at Yale University School of Medicine. Dr. Zhong was an Assistant and Associate Professor at the University of Kansas Medical Center before he joined UConn in 2012. He is a member of American Society for Pharmacology and Experimental Therapeutics (ASPET) and International Society for the Study of Xenobiotics (ISSX) as well as other 5 scientific societies. He has served as a Councilor (2009-2012) and Chair (2021-2022) of the Division for Drug Metabolism and Disposition (DDMD) of ASPET. He currently serves on editorial boards for 6 journals, including Associate Editor and Reviews Editor of Drug Metabolism and Disposition and Associate Editor of Frontiers in Pharmacology. He also serves as an Ad Hoc reviewer on several NIH study sections. He has been funded by NIH R35, R01, and P20 grants in last 15 years. Dr. Zhong is an author in more than 100 research articles. Research in Dr. Zhong’s laboratory mainly focuses on drug metabolism, developmental pharmacology, pharmacogenomics, and personalized medicine. He also provides lectures in the courses of “Principle of Drug Action”, “Drug Discovery and Development”, “Pharmacogenomics and Personalized Medicine”, “Advance Pharmacology”, “Advance Toxicology”, and “Principle of Safety Evaluation” for UConn Pharm.D. and Ph.D. students.
For more information, contact: Bodhi Chaudhuri at 860-486-4861